Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (423) 423
Publication (78) 78
Conference Proceeding (18) 18
Book Review (16) 16
Magazine Article (2) 2
Book Chapter (1) 1
Government Document (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (278) 278
humans (256) 256
female (166) 166
male (160) 160
child (130) 130
adolescent (114) 114
child, preschool (109) 109
type 1 diabetes (108) 108
diabetes (100) 100
children (96) 96
endocrinology & metabolism (87) 87
adult (85) 85
abridged index medicus (79) 79
autoantibodies (76) 76
infant (75) 75
risk factors (68) 68
article (63) 63
research (63) 63
medical and health sciences (59) 59
medicin och hälsovetenskap (59) 59
pediatrics (57) 57
risk (56) 56
autoimmunity (55) 55
clinical medicine (52) 52
middle aged (52) 52
clinical trials (50) 50
klinisk medicin (50) 50
diabetes mellitus, type 1 - immunology (47) 47
insulin (46) 46
prospective studies (44) 44
health aspects (42) 42
endocrinology and diabetes (41) 41
endokrinologi och diabetes (41) 41
diabetes mellitus (40) 40
prevention (38) 38
age (37) 37
diabetes mellitus, type 1 - genetics (35) 35
diabetes mellitus, type 1 - prevention & control (35) 35
oncology (35) 35
autoantibodies - blood (33) 33
follow-up studies (33) 33
care and treatment (32) 32
infant, newborn (32) 32
mellitus (32) 32
young adult (32) 32
analysis (31) 31
medical research (31) 31
diagnosis (30) 30
diabetes mellitus, type 1 - epidemiology (29) 29
progression (29) 29
development and progression (28) 28
islets of langerhans - immunology (28) 28
aged (27) 27
disease progression (26) 26
glucose (26) 26
relatives (25) 25
united states (25) 25
glucose tolerance test (22) 22
usage (22) 22
diabetes mellitus, type 1 - diagnosis (21) 21
double-blind method (21) 21
original research (21) 21
prediction (21) 21
studies (21) 21
cohort studies (20) 20
diabetes mellitus, type 1 - blood (20) 20
environmental determinants (20) 20
genetic predisposition to disease (20) 20
peptides (20) 20
autoantibodies - immunology (19) 19
disease (19) 19
epidemiology (19) 19
genotype (19) 19
histocompatibility antigen hla (19) 19
medicine, experimental (19) 19
medicine, general & internal (19) 19
medicine, research & experimental (19) 19
onset (19) 19
prognosis (18) 18
antibodies (17) 17
genetic aspects (17) 17
glutamate decarboxylase - immunology (17) 17
health risk assessment (17) 17
immunology (17) 17
infants (17) 17
patients (17) 17
therapy (17) 17
cancer (16) 16
diabetes mellitus, type 1 - etiology (16) 16
diabetes mellitus, type 1 - metabolism (16) 16
glutamic-acid decarboxylase (16) 16
risk assessment (16) 16
autoimmune diseases (15) 15
beta-cell function (15) 15
chemotherapy (15) 15
iddm (15) 15
incidence (15) 15
islets of langerhans (15) 15
pancreas (15) 15
proportional hazards models (15) 15
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Prognostic classification factors associated with development of multiple autoantibodies, dysglycemia, and type 1 Diabetesd - A recursive partitioning analysis
by Xu, Ping and Krischer, Jeffrey P
Diabetes Care, ISSN 0149-5992, 06/2016, Volume 39, Issue 6, pp. 1036 - 1044
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Reply
by Langford, Carol A and Krischer, Jeffrey P and Merkel, Peter A
Arthritis & Rheumatology, ISSN 2326-5191, 07/2017, Volume 69, Issue 7, pp. 1505 - 1506
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Reply
by Carol A Langford and Jeffrey P Krischer and Peter A Merkel
Arthritis & Rheumatology, ISSN 2326-5191, 07/2017, Volume 69, Issue 7, p. 1505
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Reply
by Langford, Carol A and Krischer, Jeffrey P and Merkel, Peter A
Arthritis and Rheumatology, ISSN 2326-5191, 07/2017, Volume 69, Issue 7, pp. 1505 - 1506
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Reply
: LETTERS
by Langford, Carol A and Krischer, Jeffrey P and Merkel, Peter A and on behalf of the Vasculitis Clinical Research Consortium
Arthritis & Rheumatology, ISSN 2326-5191, 07/2017, Volume 69, Issue 7, pp. 1505 - 1506
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Time-Resolved Autoantibody Profiling Facilitates Stratification of Preclinical Type 1 Diabetes in Children
by Endesfelder, David and Endesfelder, David and zu Castell, Wolfgang and Zu Castell, Wolfgang and Bonifacio, Ezio and Bonifacio, Ezio and Rewers, Marian and Rewers, Marian and Hagopian, William A and Hagopian, William A and She, Jin-Xiong and She, Jin-Xiong and Lernmark, Ake and Lernmark, Åke and Toppari, Jorma and Toppari, Jorma and Vehik, Kendra and Williams, Alistair J.K and Williams, Alistair J K and Yu, Liping and Yu, Liping and Akolkar, Beena and Krischer, Jeffrey P and Ziegler, Anette G and Ziegler, Anette-G and Achenbach, Peter and Achenbach, Peter and TEDDY Study Grp and TEDDY Study Group and Lund University and Diabetes och celiaki and Diabetes and Celiac Unit and Lunds universitet and EXODIAB: Excellence in Diabetes Research in Sweden
Diabetes, ISSN 0012-1797, 01/2019, Volume 68, Issue 1, pp. 119 - 130
Progression to clinical type 1 diabetes varies among children who develop beta-cell autoantibodies. Differences in autoantibody patterns could relate to... 
RESPIRATORY-INFECTIONS | ANTIBODIES | RELATIVES | AUTOIMMUNITY | APPEARANCE | ISLET AUTOANTIBODIES | ENVIRONMENTAL DETERMINANTS | ENDOCRINOLOGY & METABOLISM | RISK | PROGRESSION | PREDICTION | Usage | Type 1 diabetes | Analysis | Development and progression | Wavelet analysis | Children | Health aspects | Risk factors | Immunoglobulins | Autoantibodies | Insulinoma | Diabetes mellitus | Diabetes mellitus (insulin dependent) | Glutamate decarboxylase | Insulin | Seroconversion | Cells | Children & youth | Etiology | Histocompatibility antigen HLA | Diabetes | Index Medicus | Abridged Index Medicus | Clinical Medicine | Endokrinologi och diabetes | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap | Endocrinology and Diabetes
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Predicting islet cell autoimmunity and type 1 diabetes: An 8-year teddy study progress report
by Krischer, Jeffrey P and Liu, Xiang and Vehik, Kendra and Akolkar, Beena and Hagopian, William A and Rewers, Marian J and She, Jin-Xiong and Toppari, Jorma and Ziegler, Anette G and Lernmark, Ake and TEDDY Study Group and TEDDY Study Grp and the TEDDY Study Group
Diabetes Care, ISSN 0149-5992, 06/2019, Volume 42, Issue 6, pp. 1051 - 1060
Assessment of the predictive power of The Environmental Determinants of Diabetes in the Young (TEDDY)-identified risk factors for islet autoimmunity (IA), the... 
AUTOANTIBODIES | ENVIRONMENTAL DETERMINANTS | ENDOCRINOLOGY & METABOLISM | RISK | ASSOCIATION | CURVES | AGE | Islet cell stimulating antibodies | Autoantibodies | Research | Type 1 diabetes | Risk assessment | Analysis | Diabetes mellitus | Health risks | Diabetes mellitus (insulin dependent) | Single-nucleotide polymorphism | Glutamate decarboxylase | Risk analysis | Insulin | Gene polymorphism | Risk factors | Time dependence | Prediction models | Predictions | Histocompatibility antigen HLA | Research design | Diabetes | Children | Polymorphism | Protein-tyrosine-phosphatase | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Assessing disease experience across the life span for individuals with osteogenesis imperfecta: Challenges and opportunities for patient-reported outcomes (PROs) measurement: A pilot study
by Tosi, Laura L and Floor, Marianne K and Dollar, Christina M and Gillies, Austin P and Lee, Brendan and Nagamani, Sandesh C. S and Rauch, Frank and Glorieux, Francis and Retrouvey, Jean-Marc and Esposito, Paul and Rush, Eric and Bober, Michael and Eyre, David and Gomez, Danielle and Harris, Gerald and Jain, Mahim and Krakow, Deborah and Orwoll, Eric and Raggio, Cathleen and Smith, Peter and Hart, Tracy S and Cuthbertson, David D and Sutton, V. Reid and Krischer, Jeffrey P and Brittle Bone Dis Consortium and Members of the Brittle Bone Disease Consortium
Orphanet Journal of Rare Diseases, ISSN 1750-1172, 01/2019, Volume 14, Issue 1, pp. 23 - 23
BackgroundPatient reported outcome (PRO) information is crucial for establishing better patient-provider communication, improving shared decision-making... 
Patient-reported outcome measurement information system® (PROMIS®) | Patient reported outcomes | Rare disease | Osteogenesis imperfecta | Health-related quality of life (HRQoL) | Registry | Pediatric outcomes data collection instrument (PODCI) | MEDICINE, RESEARCH & EXPERIMENTAL | CLASSIFICATION | CONTACT REGISTRY | CHILDREN | NOSOLOGY | GENETICS & HEREDITY | Patient-reported outcome measurement information system (R) (PROMIS (R)) | HEALTH OUTCOMES | Physician and patient | Care and treatment | Analysis | Outcome and process assessment (Health Care) | Development and progression | Patient satisfaction | Pediatrics | Decision making | Therapeutic applications | Feasibility studies | Data processing | Research | Bone diseases | Patients | Information systems | Quality of life | Recruitment | Consortia | Validity | Life span | Questionnaires | Surgeons | Natural history | Osteogenesis | Communication | Validation studies | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Early childhood gut microbiomes show strong geographic differences among subjects at high risk for type 1 diabetes
by Kemppainen, Kaisa M and Ardissone, Alexandria N and Davis-Richardson, Austin G and Fagen, Jennie R and Gano, Kelsey A and León-Novelo, Luis G and Vehik, Kendra and Casella, George and Simell, Olli and Ziegler, Anette G and Rewers, Marian J and Lernmark, Åke and Hagopian, William and She, Jin-Xiong and Krischer, Jeffrey P and Akolkar, Beena and Schatz, Desmond A and Atkinson, Mark A and Triplett, Eric W and TEDDY Study Grp and TEDDY Study Group and Lund University and Diabetes och celiaki and Diabetes and Celiac Unit and Lunds universitet and EXODIAB: Excellence in Diabetes Research in Sweden
Diabetes Care, ISSN 0149-5992, 02/2015, Volume 38, Issue 2, pp. 329 - 332
OBJECTIVEGut microbiome dysbiosis is associated with numerous diseases, including type 1 diabetes. This pilot study determines how geographical location... 
EUROPE | CELL AUTOIMMUNITY | INTESTINAL MICROBIOTA | INFANTS | ENDOCRINOLOGY & METABOLISM | CHILDREN | Diabetes Mellitus, Type 1 - epidemiology | RNA, Ribosomal, 16S - metabolism | Residence Characteristics | United States - epidemiology | Microbiota - physiology | Humans | Risk Factors | Child, Preschool | Infant | Male | Sweden - epidemiology | Gram-Negative Bacteria - isolation & purification | Germany - epidemiology | Feces - microbiology | Pilot Projects | Intestines - microbiology | Diabetes Mellitus, Type 1 - microbiology | Gram-Positive Bacteria - isolation & purification | Female | Finland - epidemiology | Care and treatment | Bifidobacterium | Distribution | Diabetes in children | Infants | Dysbiosis | Risk factors | Babies | Pediatrics | Genotype & phenotype | Microbiology | Gram-negative bacteria | Diabetes | Health risk assessment | Index Medicus | Novel Communications in Diabetes | Clinical Medicine | Endokrinologi och diabetes | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap | Endocrinology and Diabetes
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Genetic contribution to the divergence in type 1 diabetes risk between children from the general population and children from affected families
by Hippich, Markus and Beyerlein, Andreas and Hagopian, William A and Krischer, Jeffrey P and Vehik, Kendra and Knoop, Jan and Winker, Christiane and Toppari, Jorma and Lernmark, Åke and Rewers, Marian J and Steck, Andrea K and She, Jin-Xiong and Akolkar, Beena and Robertson, Catherine C and Onengut-Gumuscu, Suna and Rich, Stephen S and Bonifacio, Ezio and Ziegler, Anette G and TEDDY Study Grp and TEDDY Study Group and the TEDDY Study Group
Diabetes, ISSN 0012-1797, 04/2019, Volume 68, Issue 4, pp. 847 - 857
The risk for autoimmunity and subsequently type 1 diabetes is 10-fold higher in children with a first-degree family history of type 1 diabetes (FDR children)... 
ISLET AUTOANTIBODIES | SUSCEPTIBILITY | ENDOCRINOLOGY & METABOLISM | HAPLOTYPES | EXPRESSION | SARCOIDOSIS | PREDICTION | Autoantibodies | Risk groups | Diabetes mellitus | Diabetes mellitus (insulin dependent) | Histocompatibility antigen HLA | Diabetes | Children | Risk factors | Genotypes | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Progression from islet autoimmunity to clinical type 1 diabetes is influenced by genetic factors: Results from the prospective TEDDY study
by Beyerlein, Andreas and Bonifacio, Ezio and Vehik, Kendra and Hippich, Markus and Winkler, Christiane and Frohnert, Brigitte I and Steck, Andrea K and Hagopian, William A and Krischer, Jeffrey P and Lernmark, Åke and Rewers, Marian J and She, Jin-Xiong and Toppari, Jorma and Akolkar, Beena and Rich, Stephen S and Ziegler, Anette-G and TEDDY Study Group and Lund University and Diabetes och celiaki and Diabetes and Celiac Unit and Lunds universitet and EXODIAB: Excellence in Diabetes Research in Sweden
Journal of Medical Genetics, ISSN 0022-2593, 2018, Volume 56, Issue 9, pp. 602 - 605
Progression time from islet autoimmunity to clinical type 1 diabetes is highly variable and the extent that genetic factors contribute is unknown. In 341 islet... 
diagnostics tests | epidemiology | immunology (including allergy) | diabetes | Antigens | Autoantibodies | Risk groups | Laboratories | Diabetes mellitus | Diabetes mellitus (insulin dependent) | Family medical history | Studies | Genotype & phenotype | Diabetes | Children | Genetic factors | Health risk assessment | Autoimmune diseases | Age | Genotypes | Antigenic determinants | Index Medicus | Basic Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Klinisk medicin | Medicinsk genetik | Medical Genetics | Clinical Medicine | Endokrinologi och diabetes | Medicinska och farmaceutiska grundvetenskaper | Endocrinology and Diabetes
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Low-dose anti-thymocyte globulin preserves C-peptide, reduces HbA1c, and increases regulatory to conventional T-cell ratios in new-onset type 1 diabetes: Two-year clinical trial data
by Haller, Michael J and Alice Long, S and Lori Blanchfield, J and Schatz, Desmond A and Skyler, Jay S and Krischer, Jeffrey P and Bundy, Brian N and Geyer, Susan M and Warnock, Megan V and Miller, Jessica L and Atkinson, Mark A and Becker, Dorothy J and Baidal, David A and DiMeglio, Linda A and Gitelman, Stephen E and Goland, Robin and Gottlieb, Peter A and Herold, Kevan C and Marks, Jennifer B and Moran, Antoinette and Rodriguez, Henry and Russell, William E and Wilson, Darrell M and Greenbaum, Carla J
Diabetes, ISSN 0012-1797, 06/2019, Volume 68, Issue 6, pp. 1267 - 1276
A three-arm, randomized, double-masked, placebo-controlled phase 2b trial performed by the Type 1 Diabetes TrialNet Study Group previously demonstrated that... 
Flow cytometry | Peptides | PD-1 protein | CD8 antigen | Diabetes mellitus | Clinical trials | Diabetes mellitus (insulin dependent) | Lymphocytes T | Immunological tolerance | CD4 antigen | Thymocytes | Globulins | Granulocyte colony-stimulating factor | Colony-stimulating factor | Diabetes | Leukocytes (granulocytic) | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text The rare diseases clinical research network's organization and approach to observational research and health outcomes research
by Krischer, Jeffrey P and Gopal-Srivastava, Rashmi and Groft, Stephen. C and Eckstein, David J and Rare Dis Clinical Res Network and Rare Diseases Clinical Research Network
Journal of General Internal Medicine, ISSN 0884-8734, 2014, Volume 29, Issue 3, pp. S739 - S744
Established in 2003 by the Office of Rare Diseases Research (ORDR), in collaboration with several National Institutes of Health (NIH) Institutes/Centers, the... 
rare diseases network | outcomes | patient advocacy groups | multi-institutional clinical research | SYSTEM | MEDICINE, GENERAL & INTERNAL | HEALTH CARE SCIENCES & SERVICES | QUALITY-OF-LIFE | VASCULITIS | CONTACT REGISTRY | CHALLENGES | CHILDREN | Datasets as Topic | United States | Humans | Cooperative Behavior | Registries | Rare Diseases | Outcome Assessment (Health Care) - organization & administration | Research Design | Medicine, Experimental | Clinical trials | Medical research | Health aspects | Advocacy | Disease | Patients | Clinical outcomes | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text A model-based approach to sample size estimation in recent onset type 1 diabetes
: Sample Size Estimation
by Bundy, Brian N and Krischer, Jeffrey P and Type 1 Diabetes TrialNet Study Group
Diabetes/Metabolism Research and Reviews, ISSN 1520-7552, 11/2016, Volume 32, Issue 8, pp. 827 - 834
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Nested case-control data analysis using weighted conditional logistic regression in The Environmental Determinants of Diabetes in the Young (TEDDY) study: A novel approach
by Lee, Hye-Seung and Lynch, Kristian F and Krischer, Jeffrey P and TEDDY Study Group and the TEDDY Study Group
Diabetes/metabolism research and reviews, ISSN 1520-7552, 07/2019, pp. e3204 - e3204
A nested case-control (NCC) design within a prospective cohort study can realize substantial benefits for biomarker studies. In this context, it is natural to... 
Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis
by McCormack, Francis X and Inoue, Yoshikazu and Moss, Joel and Singer, Lianne G and Strange, Charlie and Nakata, Koh and Barker, Alan F and Chapman, Jeffrey T and Brantly, Mark L and Stocks, James M and Brown, Kevin K and Lynch, Joseph P and Goldberg, Hilary J and Young, Lisa R and Kinder, Brent W and Downey, Gregory P and Sullivan, Eugene J and Colby, Thomas V and McKay, Roy T and Cohen, Marsha M and Korbee, Leslie and Taveira-DaSilva, Angelo M and Lee, Hye-Seung and Krischer, Jeffrey P and Trapnell, Bruce C and Natl Inst Hlth Rare Lung Dis Conso and MILES Trial Grp and MILES Trial Group and National Institutes of Health Rare Lung Diseases Consortium
The New England Journal of Medicine, ISSN 0028-4793, 04/2011, Volume 364, Issue 17, pp. 1595 - 1606
This trial showed that in patients with lymphangioleiomyomatosis (LAM), a progressive, cystic lung disease in women, sirolimus therapy was associated with... 
CELLS | MEDICINE, GENERAL & INTERNAL | TUBEROUS SCLEROSIS COMPLEX | PROGESTERONE | MECHANISM | PULMONARY LYMPHANGIOLEIOMYOMATOSIS | LUNG-FUNCTION | LYMPHANGIOGENESIS | PROGRESSION | TRANSPLANTATION | DECLINE | Sirolimus - therapeutic use | Double-Blind Method | Forced Expiratory Volume - drug effects | Humans | Lymphangioleiomyomatosis - physiopathology | Middle Aged | Lymphangioleiomyomatosis - drug therapy | Sirolimus - blood | TOR Serine-Threonine Kinases - antagonists & inhibitors | Vital Capacity - drug effects | Medication Adherence | Intention to Treat Analysis | Observation | Quality of Life | Adult | Female | Sirolimus - adverse effects | Diagnosis | Drug therapy | Lung diseases | Patient outcomes | Human subjects | Lungs | Kinases | Womens health | Vascular endothelial growth factor | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights